Format

Send to

Choose Destination
BMJ Case Rep. 2013 Jun 18;2013. pii: bcr2013009523. doi: 10.1136/bcr-2013-009523.

Refractory PMR with aortitis: life-saving treatment with anti-IL6 monoclonal antibody (tocilizumab) and surgical reconstruction of the ascending aorta.

Author information

1
Department of Rheumatology, University Hospital Limerick, Limerick, Ireland. fahd_adeeb@yahoo.com

Abstract

Aortitis is uncommon but well described in patients with polymyalgia rheumatica (PMR). While glucocorticoid remains the mainstay therapy for large-vessel vasculitis, there have been cases where tocilizumab therapy led to clinical and serological improvement in patients with relapsing or refractory disease. We report a case of life-threatening PMR with aortitis in the absence of manifestations related to giant cell arteritis, which, having failed to respond to corticosteroid therapy, was successfully treated with tocilizumab and emergency reconstruction of the ascending aorta. This case adds to the literature supporting the potential value of interleukin-6 inhibition in rare rheumatological conditions such as inflammatory aortitis.

PMID:
23780768
PMCID:
PMC3702847
DOI:
10.1136/bcr-2013-009523
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center